Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | CD52 |
| Upstream (Parents) |
|---|
| (<<) CD53 → CD52 |
| (<<) TYROBP → CD52 |
| (<<) GMFG → CD52 |
| (<<) SASH3 → CD52 |
| Downstream (Children) |
|---|
| CD52 → AP1S2 (>>) |
| CD52 → MRAS (>>) |
| CD52 → CORO1A (>>) |
| CD52 → IMMP2L (>>) |
| CD52 → MMP23A///MMP23B (>>) |
| CD52 → UCP2 (>>) |
| CD52 → CD6 (>>) |
| CD52 → SPIB (>>) |
| CD52 → DOK2 (>>) |
| CD52 → IGHD (>>) |
| CD52 → SYT1 (>>) |
| CD52 → TAAR3 (>>) |
| CD52 → LTK (>>) |
| CD52 → MFSD7 (>>) |
